Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Ruxolitinib treatment may cause eyelash growth.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Reducing FOXA2 in skin cells lowers their ability to grow hair.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Compound 4 is a promising treatment for hair loss with low toxicity.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Spironolactone does not increase the risk of breast cancer recurrence.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Australian dermatologists often prescribe spironolactone and minoxidil for female hair loss.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

Systemic cyproterone acetate and 5% topical minoxidil are effective and safe for treating female pattern hair loss.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.